TRex Bio
Michael Baran serves as Partner at Pfizer Ventures and holds multiple executive roles at Pfizer, including Executive Director for Emerging Science & Innovation in Oncology, Senior Director of Strategic Portfolio Management, and Senior Director of External R&D Innovation for the Asia Pacific Strategy. Additionally, Michael contributes to academia as an Adjunct Assistant Professor in the Department of Biomedical Engineering at Stony Brook University and holds board positions at several biotechnology companies, including Imcheck Therapeutics, ImmunOs Therapeutics AG, and Mediar Therapeutics. Michael's educational background includes a PhD in Biochemistry from Rutgers University, an MBA in Pharmaceutical Management, and a Venture Capital Certificate from the University of Michigan's Stephen M. Ross School of Business.
This person is not in the org chart
This person is not in any offices
TRex Bio
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.